Abstract: Arrangements related to carbon flocked tape are described. The flocked tape can include a first adhesive, a substrate, a second adhesive, and a plurality of fibers. The substrate can be formed from any suitable metal, polymer, and/or natural material. The fibers can be formed from milled recycled carbon fibers. The carbon fibers can be connected within the tape via an electrostatic flocking process. The flocked tape can allow for application, removal, and re-application. The carbon flocked tape can provide several benefits, such as electric and/or thermal conductivity, noise and vibration reduction, insulation and shielding, and altered fluid dynamics.

Abstract: A cargo organizer includes a base, a storage compartment supported by the base and a deployment system for the storage compartment. The storage compartment includes a plurality of wall panels each having a hinged connection with the base and pivotable about its hinged connection between a stowed orientation and an upright orientation. The storage compartment is selectively deployable between a collapsed condition and an open condition. In the collapsed condition, each wall panel is lowered to its stowed orientation while, in the open condition, each wall panel is raised to its upright orientation. In the collapsed condition, the wall panels include an underlying wall panel and two adjacent overlying wall panels in spaced opposition about the underlying wall panel. The deployment system includes a strap system that connects an inboard portion of the underlying wall panel to respective outboard portions of the two adjacent overlying wall panels.

Abstract: The invention is a method of measuring blood glucose excursions in general, and postprandial hyperglycemia in diabetic patients in particular, by the 1,5-anhydroglucitol assay (1,5-AG) or A1C/1,5-AG assay combination. 1,5-AG levels and percent changes of 1,5-AG levels in short period are indicative of differing postmeal glucose levels in moderately-controlled diabetic patients with similar A1C levels. Thereby 1,5-AG assay is useful to identify diabetic patients who may be at risk for cardiovascular complications which would not be identifiable by A1C levels alone. Furthermore, ratios of A1C divided by 1,5-AG in each patient are superior indicators to 1,5-AG levels.

Abstract: HbA1c measurement is a critical component of diabetes management; however, a key limitation of HbA1c as a measure of glycemia is the lack of timeliness—it does not detect underlying blood glucose excursion levels in moderately controlled diabetic patients (HbA1c<8) as it is a measurement of mean glucose levels over the longer-term. HbA1c also averages both hypo- and hyperglycemia over two to three months; therefore, it does not adequately reflect improvements in post-prandial hyperglycemia. 1,5-AG is also a marker of glycemic control over a shorter one to two week timeframe, but with a different mechanism than HbA1c. Given the unique biological and physiological characteristics of 1,5-AG, it is sensitive to acute and transient episodes of hyper-glycemia and is, therefore, a better indicator of glucose excursions. Peptidyl diabetic drugs such as pramlintide and exenatide have unique mechanisms of action and the glycemic effects of these drugs are not adequately shown by HbA1c.

Abstract: The invention is a method of measuring blood glucose excursions in general, and postprandial hyperglycemia in diabetic patients in particular, by the 1,5-anhydroglucitol assay (1,5-AG) or A1C/1,5-AG assay combination. 1,5-AG levels and percent changes of 1,5-AG levels in short period are indicative of differing postmeal glucose levels in moderately-controlled diabetic patients with similar A1C levels. Thereby 1,5-AG assay is useful to identify diabetic patients who may be at risk for cardiovascular complications which would not be identifiable by A1C levels alone. Furthermore, ratios of A1C divided by 1,5-AG in each patient are superior indicators to 1,5-AG levels.